Hospice News May 8, 2024
Amedisys Inc. (NASDAQ: AMED) has agreed to divest upwards of 100 home health and hospice locations to an undisclosed private equity buyer as the company addresses regulators’ antitrust concerns in its pending acquisition by the UnitedHealth Group’s (UNH) health care services arm Optum.
The news came in a recent social media post from The Capitol Forum. Selling off some of Amedisys’ locations in overlapping markets within Optum’s service region may help push the transaction forward amid mounting regulatory concerns.
The U.S. Department of Justice (DOJ) is mulling a possible lawsuit to block the acquisition, citing potential antitrust issues related to the deal. The concerns center around the ability for other providers to compete if Optum and Amedisy combine their geographic...
Today's Sponsors
Today's Sponsor